» Articles » PMID: 1697589

Molecular Cloning and Expression of Human Tumor-associated Polymorphic Epithelial Mucin

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 1990 Sep 5
PMID 1697589
Citations 236
Authors
Affiliations
Soon will be listed here.
Abstract

Human mammary cells present on the cell surface a polymorphic epithelial mucin (PEM) which is developmentally regulated and aberrantly expressed in tumors. PEM carries tumor-associated epitopes recognized by the monoclonal antibodies HMFG-1, HMFG-2, and SM-3. Previously isolated partial cDNA clones revealed that the core protein contained a large domain consisting of variable numbers of 20-amino acid repeat units. We now report the full sequence for PEM, as deduced from cDNA sequences. The encoded protein consists of three distinct regions: the amino terminus consisting of a putative signal peptide and degenerate repeats; the major portion of the protein which is the tandem repeat region; the carboxyl terminus consisting of degenerate tandem repeats and a unique sequence containing a transmembrane sequence and a cytoplasmic tail. Potential O-glycosylation sites (serines or threonines) make up more than one-fourth of the amino acids. Length variations in the tandem repeat result in PEM being an expressed variable number tandem repeat locus. Tandem repeats appear to be a general characteristic of mucin core proteins.

Citing Articles

Mucins as Precision Biomarkers in Glioma: Emerging Evidence for Their Potential in Biospecimen Analysis and Outcome Prediction.

Erickson A, Jackson L, Camphausen K, Krauze A Biomedicines. 2025; 12(12.

PMID: 39767713 PMC: 11673638. DOI: 10.3390/biomedicines12122806.


Re-localization of a repeat-containing fungal effector by apoplastic protein Chitinase-like 1 blocks its toxicity.

Liu H, Zhang W, He Q, Aikemu R, Xu H, Guo Z Nat Commun. 2024; 15(1):10122.

PMID: 39578470 PMC: 11584738. DOI: 10.1038/s41467-024-54470-0.


Combination strategies with PARP inhibitors in BRCA-mutated triple-negative breast cancer: overcoming resistance mechanisms.

Jain A, Barge A, Parris C Oncogene. 2024; 44(4):193-207.

PMID: 39572842 PMC: 11746151. DOI: 10.1038/s41388-024-03227-6.


Preventative Cancer Vaccine-Elicited Human Anti-MUC1 Antibodies Have Multiple Effector Functions.

McKeague M, Lohmueller J, Dracz M, Saadallah N, Ricci E, Beckwith D Antibodies (Basel). 2024; 13(4.

PMID: 39449327 PMC: 11503386. DOI: 10.3390/antib13040085.


Unraveling the role of C1GALT1 in abnormal glycosylation and colorectal cancer progression.

Tian H, Yu J, Chu X, Guan Q, Liu J, Liu Y Front Oncol. 2024; 14:1389713.

PMID: 38699634 PMC: 11063370. DOI: 10.3389/fonc.2024.1389713.